Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
Medtronic Dips: Is Now the Time to Buy?: https://www.marketbeat.com/logos/articles/med_20240523121523_chart-mdt-5232024ver001.png
Medtronic Dips: Is Now the Time to Buy?

Shares of Medtronic (NYSE: MDT) are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow

2 Stocks Providing Medical Insurance for Your Pets: https://www.marketbeat.com/logos/articles/med_20240519155501_chart-trup.jpg
2 Stocks Providing Medical Insurance for Your Pets

The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can

CVS Health Stock Has a Silver Lining Called Value: https://www.marketbeat.com/logos/articles/med_20240519153028_chartzy-cvs.jpg
CVS Health Stock Has a Silver Lining Called Value

Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line

Undervalued UnitedHealth Group Won’t Be For Long: https://www.marketbeat.com/logos/articles/med_20240416091545_chart-unh-4162024ver001.png
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Novo Nordisk Arms Wegovy to Be a Triple Threat: https://www.marketbeat.com/logos/articles/med_20240414165029_charts-nvo.jpg
Novo Nordisk Arms Wegovy to Be a Triple Threat

Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label

DexCom Stock Gains from GLP-1 Diabetic Users: https://www.marketbeat.com/logos/articles/med_20240331131923_chart-dxcm.jpg
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System: https://www.irw-press.at/prcom/images/messages/2024/73936/14032024_EN_Medmira.001.png
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System

Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test

MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem: https://www.irw-press.at/prcom/images/messages/2024/73936/14032024_DE_Medmira.001.png
MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem

Halifax, Nova Scotia, 13. März 2024 - Heute gibt MedMira Inc. (MedMira) (TSXV: MIR) den Erhalt eines kanadischen Patents (Nummer 2.949.634) für sein neues innovatives und quantitatives

Medtronic is a Dividend Aristocrat That Keeps Gaining: https://www.marketbeat.com/logos/articles/med_20240310135440_charts-mdt.jpg
Medtronic is a Dividend Aristocrat That Keeps Gaining

Medical device maker Medtronic PLC (NYSE: MDT) is a Dividend Aristocrat in the medical and healthcare sectors. The medical device maker has raised its dividend payout for 46 consecutive years

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?: https://www.marketbeat.com/logos/articles/med_20240304134833_is-unitedhealth-group-stock-a-strong-buy-or-a-fall.jpg
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?

UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024

Can UnitedHealth Group afford to keep Medicare Advantage plans?: https://www.marketbeat.com/logos/articles/med_20240218165851_can-unitedhealth-group-afford-to-keep-medicare-adv.jpg
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit

Why Cigna stock will be at fresh highs by March: https://www.marketbeat.com/logos/articles/med_20240207143124_why-cigna-stock-will-be-at-fresh-highs-by-march.jpg
Why Cigna stock will be at fresh highs by March

The Cigna Group’s (NYSE: CI) 35% rally that started last summer just hit a new high gear. While investors would have been spooked by the 20% slide from November into December, all that damage has

Is Humana’s pain HCA Healthcare’s gain?: https://www.marketbeat.com/logos/articles/med_20240204124713_chart-hca2.jpg
Is Humana’s pain HCA Healthcare’s gain?

HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including

Goldman Sachs looks poised for a breakout: https://www.marketbeat.com/logos/articles/med_20240205091820_goldman-sachs-looks-poised-for-a-breakout.jpg
Goldman Sachs looks poised for a breakout

The Goldman Sachs Group (NYSE: GS) is one of the most-followed stocks and has long been an industry leader and at the forefront of innovation in the banking and financial sector

The company

Med-tech stock Conmed dips ahead of big Q4 report...opportunity?: https://www.marketbeat.com/logos/articles/med_20240129182456_med-tech-stock-conmed-dips-ahead-of-big-q4-report.jpg
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?

When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in

4 med tech stocks with improving prognosis for 2024: https://www.marketbeat.com/logos/articles/med_20240130110415_chart-jnj-1302024ver001.png
4 med tech stocks with improving prognosis for 2024

Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to

Humana EPS shocker. Are Medicare Advantage plans in jeopardy?: https://www.marketbeat.com/logos/articles/med_20240129150334_humana-eps-shocker.jpg
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?

Health insurance carrier Humana Inc. (NYSE: HUM) reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also

5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg
5 top healthcare stocks for earnings growth in 2024

While the healthcare sector delivered lackluster profit growth in 2023, it should change this year. 

Sector components forecast to show the biggest earnings year-over-year earnings improvement

UnitedHealth's rising premiums could cushion stubborn inflation: https://www.marketbeat.com/logos/articles/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg
UnitedHealth's rising premiums could cushion stubborn inflation

When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.

Medtronic receives FDA approval for deep brain stimulation system: https://www.marketbeat.com/logos/articles/med_20240114164045_chart-mdt2.jpg
Medtronic receives FDA approval for deep brain stimulation system

Medtronic PLC (NYSE: MDT), a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation

Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

UnitedHealth Group Looks Buyable After AI-Fueled Double Beat: https://www.marketbeat.com/logos/articles/med_20240112120135_unitedhealth-group-looks-buyable-after-ai-fueled-d.jpg
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat

The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on

HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg
HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back. 

Investors